Sensorion Provides Update on Hearing Loss Gene Therapies
The company highlights progress in its SENS-501 and GJB2-GT clinical programs, recent financing, and a leadership transition.
Tag: cisplatin ototoxicity
All
Latest
All
Latest
Acousia to Present PROHEARÂ Study on Hearing Loss Treatment for Cancer Patients
The PROHEAR study is a placebo-controlled Phase 2a study investigating the otoprotective efficacy of ACOU085 in patients with testicular cancer undergoing cisplatin-based chemotherapy.
